Healthwell Acquisition Corp. I
NASDAQ:HWEL
10.475 (USD) • At close November 28, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 1.195 | 0.375 | 1.423 | 0.555 | 0.263 | 0 | 0 | 0 | 0 |
| Brutowinst
| -1.195 | -0.375 | -1.423 | -0.555 | -0.263 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 0 | 0.318 | 0 | 0 | 0.318 | 0 | 0.157 | 0.006 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 0.001 | 0 | -0.318 | 0.001 | 0 | 0.318 | 0 | 0.157 | 0.006 |
| Overige kosten
| -0 | 0.426 | 0.656 | 0.605 | 0.314 | 0 | -0.441 | -1.021 | 0 |
| Bedrijfskosten
| 1.245 | 0.426 | 0.338 | 0.605 | 0.314 | 0.368 | -0.441 | 0.288 | 0.006 |
| Bedrijfsresultaat
| -1.245 | 0.934 | -0.338 | -0.605 | -0.314 | -0.368 | -0.441 | -0.288 | -0.006 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 0.65 | 1.359 | 4.43 | 0.64 | 2.958 | 5.768 | -0.976 | 6.266 | 0 |
| Inkomen voor belasting
| -0.595 | 0.933 | 4.092 | 0.036 | 2.644 | 5.4 | -1.48 | 5.978 | -0.006 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0.65 | 0.557 | 0.476 | 0.283 | -2.429 | 0 | 1.039 | 1.021 | 0 |
| Nettowinst
| -1.246 | 0.376 | 3.616 | -0.248 | 5.074 | 5.4 | -2.52 | 5.978 | -0.006 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.04 | 0.012 | 0.21 | -0.008 | 0.16 | 0.17 | -0.12 | 0.28 | -0 |
| Verwaterde WPA
| -0.04 | 0.012 | 0.21 | -0.008 | 0.16 | 0.17 | -0.12 | 0.28 | -0 |
| EBITDA
| -1.245 | -0.426 | -4.767 | -0.605 | -0.314 | -0.368 | -1.48 | -0.288 | -0.006 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |